Medicare Transaction Facilitator
-
340B, Caught my eye, Drug Prices, Generics, Inflation Reduction Act, Medicare Negotiation, Medicare Part D, Medicare Transaction FacilitatorCaught my eye — 8/23/24
Read more: Caught my eye — 8/23/24It’s an Inflation Reduction Act (IRA) hangover kind of week. Last week the first Medicare negotiated prices for 2026 were announced and this week is the “what does this mean?” week with everyone catching up and chiming in. What I wrote last week stands but if you want another review, Health Affairs/KFF has you covered.…
-
No Time for Patience
Read more: No Time for PatienceToday I’m doing a presentation for patient advocates on the Initial Price Applicability Year (IPAY) Guidance 2027 that the Centers for Medicare & Medicaid Services put out a few weeks ago. I thought you might enjoy the overview as well. Long story short – the guidance is focused on the Medicare negotiation process for 2027.…
-
340B, Caught my eye, Drug Prices, Employers, Healthcare Costs, ICER, Inflation Reduction Act, Medicare Negotiation, Medicare Part D, Medicare Transaction Facilitator, Reference Pricing, ValueCaught my eye — 5/10/24
Read more: Caught my eye — 5/10/24Back to back. Arnold Ventures put out the latest anti-pharma talking points (h/t Brian Reid) and here were two back to back – Here’s the problem, it really isn’t about the cost of drugs. I mean you could take that drug price and reduce it 98% and the 25% cost share would still be too…
-
Could have used the Easy Button
Read more: Could have used the Easy ButtonThe Inflation Reduction Act (IRA) is a little fuzzy on the details of how Medicare negotiated prices get into the system. It says that pharmacies need to be able to purchase at this price but is silent about the mechanics. This stuff is hard. But gosh sometimes I feel like the implementation could be so…
Latest news
- Caught my eye — 9/13/24
- More MP3 Math (3M of M3P)
- Caught my eye — 09/06/24
- MP3 Take 2
- Caught my eye — 8/30/24
Categories
- 340B (22)
- Affordable Care Act (3)
- Alzheimer's (4)
- Biosimilars (16)
- Caught my eye (38)
- Chevron Deference (2)
- CMMI (7)
- Copay Accumulators (6)
- COVID (2)
- Drug Prices (19)
- Drug shortages (6)
- DTC (2)
- Employers (6)
- Generics (3)
- Health Equity (2)
- Healthcare Costs (18)
- ICER (4)
- Importation (2)
- Inflation Reduction Act (37)
- Insulin (4)
- IP (3)
- Long term care (1)
- Medicaid (3)
- Medicare Advantage (11)
- Medicare Negotiation (35)
- Medicare Part D (31)
- Medicare Transaction Facilitator (4)
- Obesity (17)
- Orphan Drugs (1)
- Pharmacy Benefit Managers (21)
- Reference Pricing (3)
- State-based Reform (12)
- Uncategorized (3)
- Utilization Management (1)
- Vaccines (2)
- Value (7)